Your browser doesn't support javascript.
loading
Targeting B-cell malignancies through human B-cell receptor specific CD4+ T cells.
Weng, Jinsheng; Baio, Flavio Egidio; Moriarty, Kelsey E; Torikai, Hiroki; Wang, Hua; Liu, Zhiqiang; Maiti, Sourindra N; Gwak, Dongho; Popescu, Michael S; Cha, Soung-Chul; Cooper, Laurence J N; Neelapu, Sattva S; Kwak, Larry W.
Afiliación
  • Weng J; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Center Laboratory, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Baio FE; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.
  • Moriarty KE; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.
  • Torikai H; Division of Pediatrics, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.
  • Wang H; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.
  • Liu Z; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.
  • Maiti SN; Division of Pediatrics, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.
  • Gwak D; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.
  • Popescu MS; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.
  • Cha SC; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.
  • Cooper LJ; Division of Pediatrics, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.
  • Neelapu SS; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.
  • Kwak LW; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.
Oncoimmunology ; 5(11): e1232220, 2016.
Article en En | MEDLINE | ID: mdl-27999743
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncoimmunology Año: 2016 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncoimmunology Año: 2016 Tipo del documento: Article País de afiliación: China